Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 May;115(1):203–209. doi: 10.1111/j.1476-5381.1995.tb16340.x

Drug-induced defaecation in rats: role of central 5-HT1A receptors.

T Croci 1, M Landi 1, A Bianchetti 1, L Manara 1
PMCID: PMC1908762  PMID: 7647978

Abstract

1. We investigated the acute effects of 5-hydroxytryptamine (5-HT), and of the 5-HT1A receptor agonists, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), buspirone and SR 57746A, on rat faecal pellet output and water content. 2. 5-HT, 8-OH-DPAT, buspirone and SR 57746A, a new selective 5-HT1A receptor agonist, displaced [3H]-8-OH-DPAT from specific binding sites in rat hippocampus membranes (Ki, nM; 1.8, 1.2, 15, 3.1 respectively) and stimulated rat defaecation dose-dependently. SR 57746A and buspirone induced 1 g dry weight of faeces at 1.3 and 6.1 mg kg-1, p.o. (AD1) respectively. 8-OH-DPAT and 5-HT stimulated defaecation after s.c. injection (AD1, 0.07 and 7.5 mg kg-1, respectively). All these agents increased faecal water content. 3. The putative 5-HT1A receptor antagonist, pindolol, injected s.c. or i.c.v., significantly reduced the defaecation induced by systemically administered 8-OH-DPAT, buspirone or SR 57746A, but not 5-HT. 4. Pretreatment with p-chlorophenylalanine (i.p.) or 5,7-dihydroxytryptamine (i.c.v.), according to protocols designed to cause either generalized or CNS-limited 5-HT depletion respectively, also reduced the defaecation induced by buspirone or SR 57746A. 5. No specific 5-HT1A binding sites could be labelled by incubating rat colon membranes with [3H]-8-OH-DPAT, and in vitro preparations of rat colon segments showed no response to 8-OH-DPAT or SR 57746A up to 5 microM. 6. After eight days' repeated daily treatment, complete tolerance developed to the stimulant effects of SR 57746A and buspirone on faecal water content, but not on faecal pellet output.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bachy A., Steinberg R., Santucci V., Fournier M., Landi M., Hamon M., Manara L., Keane P. E., Soubrié P., Le Fur G. Biochemical and electrophysiological properties of SR 57746A, a new, potent 5-HT1A receptor agonist. Fundam Clin Pharmacol. 1993;7(9):487–497. doi: 10.1111/j.1472-8206.1993.tb00253.x. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. P., Jr, Snyder S. H. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol. 1976 May;12(3):373–389. [PubMed] [Google Scholar]
  3. Black J. W., Shankley N. P. Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach. Br J Pharmacol. 1985 Nov;86(3):601–607. doi: 10.1111/j.1476-5381.1985.tb08936.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buchheit K. H., Engel G., Mutschler E., Richardson B. Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol. 1985 Mar;329(1):36–41. doi: 10.1007/BF00695189. [DOI] [PubMed] [Google Scholar]
  5. Caccia S., Conti I., Viganò G., Garattini S. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat. Pharmacology. 1986;33(1):46–51. doi: 10.1159/000138199. [DOI] [PubMed] [Google Scholar]
  6. Carli M., Prontera C., Samanin R. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br J Pharmacol. 1989 Apr;96(4):829–836. doi: 10.1111/j.1476-5381.1989.tb11891.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cervo L., Bendotti C., Tarizzo G., Cagnotto A., Skorupska M., Mennini T., Samanin R. Potential antidepressant properties of SR 57746A, a novel compound with selectivity and high affinity for 5-HT1A receptors. Eur J Pharmacol. 1994 Feb 21;253(1-2):139–147. doi: 10.1016/0014-2999(94)90768-4. [DOI] [PubMed] [Google Scholar]
  8. Cervo L., Samanin R. Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist. Eur J Pharmacol. 1987 Dec 1;144(2):223–229. doi: 10.1016/0014-2999(87)90523-1. [DOI] [PubMed] [Google Scholar]
  9. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  10. Costa M., Furness J. B., Cuello A. C., Verhofstad A. A., Steinbusch H. W., Elde R. P. Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment. Neuroscience. 1982 Feb;7(2):351–363. doi: 10.1016/0306-4522(82)90272-x. [DOI] [PubMed] [Google Scholar]
  11. Costa M., Furness J. B. The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon. Br J Pharmacol. 1979 Feb;65(2):237–248. doi: 10.1111/j.1476-5381.1979.tb07824.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Costall B., Naylor R. J. 5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders. Scand J Gastroenterol. 1990 Aug;25(8):769–787. doi: 10.3109/00365529008999215. [DOI] [PubMed] [Google Scholar]
  13. Croci T., Basilisco G., Bassani A., Manara L. Manometric patterns of rat colonic motor activity and defecation. Effect of selective 5HT1A agonist 8-OH-DPAT. Dig Dis Sci. 1994 Sep;39(9):1968–1973. doi: 10.1007/BF02088133. [DOI] [PubMed] [Google Scholar]
  14. Croci T., Bianchetti A. Stimulation of faecal excretion in rats by alpha 2-adrenergic antagonists. J Pharm Pharmacol. 1992 Apr;44(4):358–360. doi: 10.1111/j.2042-7158.1992.tb03621.x. [DOI] [PubMed] [Google Scholar]
  15. Croci T., Emonds-Alt X., Manara L. SR 48968 selectively prevents faecal excretion following activation of tachykinin NK2 receptors in rats. J Pharm Pharmacol. 1994 May;46(5):383–385. doi: 10.1111/j.2042-7158.1994.tb03819.x. [DOI] [PubMed] [Google Scholar]
  16. Cuzzolin L., Schinella M., Tellini U., Pezzoli L., Lippi U., Benoni G. The effect of sex and cardiac failure on the pharmacokinetics of a slow-release theophylline formulation in the elderly. Pharmacol Res. 1990 Sep-Oct;22 (Suppl 1):137–138. doi: 10.1016/1043-6618(90)90846-6. [DOI] [PubMed] [Google Scholar]
  17. De Ponti F., Cosentino M., Lecchini S., Frigo G. M., Crema A. Physiopharmacology of the peristaltic reflex: an update. Ital J Gastroenterol. 1991 Jun;23(5):264–269. [PubMed] [Google Scholar]
  18. Dourish C. T., Hutson P. H., Curzon G. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Psychopharmacology (Berl) 1986;89(4):467–471. doi: 10.1007/BF02412123. [DOI] [PubMed] [Google Scholar]
  19. Galligan J. J., Surprenant A., Tonini M., North R. A. Differential localization of 5-HT1 receptors on myenteric and submucosal neurons. Am J Physiol. 1988 Nov;255(5 Pt 1):G603–G611. doi: 10.1152/ajpgi.1988.255.5.G603. [DOI] [PubMed] [Google Scholar]
  20. Gilbert F., Brazell C., Tricklebank M. D., Stahl S. M. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol. 1988 Mar 15;147(3):431–439. doi: 10.1016/0014-2999(88)90178-1. [DOI] [PubMed] [Google Scholar]
  21. Goa K. L., Ward A. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs. 1986 Aug;32(2):114–129. doi: 10.2165/00003495-198632020-00002. [DOI] [PubMed] [Google Scholar]
  22. Goodwin G. M., De Souza R. J., Green A. R. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats. Psychopharmacology (Berl) 1986;89(3):382–387. doi: 10.1007/BF00174379. [DOI] [PubMed] [Google Scholar]
  23. Goodwin G. M., De Souza R. J., Green A. R. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function. Neuropharmacology. 1985 Dec;24(12):1187–1194. doi: 10.1016/0028-3908(85)90153-4. [DOI] [PubMed] [Google Scholar]
  24. Hjorth S., Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? Eur J Pharmacol. 1986 Sep 23;129(1-2):131–138. doi: 10.1016/0014-2999(86)90344-4. [DOI] [PubMed] [Google Scholar]
  25. Hutson P. H., Donohoe T. P., Curzon G. Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol. 1987 Nov 10;143(2):221–228. doi: 10.1016/0014-2999(87)90536-x. [DOI] [PubMed] [Google Scholar]
  26. Jenkins S. W., Robinson D. S., Fabre L. F., Jr, Andary J. J., Messina M. E., Reich L. A. Gepirone in the treatment of major depression. J Clin Psychopharmacol. 1990 Jun;10(3 Suppl):77S–85S. doi: 10.1097/00004714-199006001-00014. [DOI] [PubMed] [Google Scholar]
  27. Kennett G. A., Marcou M., Dourish C. T., Curzon G. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol. 1987 Jun 12;138(1):53–60. doi: 10.1016/0014-2999(87)90336-0. [DOI] [PubMed] [Google Scholar]
  28. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  29. Landi M., Bianchetti A., Croci T., Manara L. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites. Biochem Pharmacol. 1992 Aug 18;44(4):665–672. doi: 10.1016/0006-2952(92)90401-4. [DOI] [PubMed] [Google Scholar]
  30. Martin P., Tissier M. H., Adrien J., Puech A. J. Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm. Life Sci. 1991;48(26):2505–2511. doi: 10.1016/0024-3205(91)90605-b. [DOI] [PubMed] [Google Scholar]
  31. Millan M. J., Canton H., Rivet J. M., Lejeune F., Laubie M., Lavielle G. S 14671: a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency. Eur J Pharmacol. 1991 Oct 15;203(2):319–322. doi: 10.1016/0014-2999(91)90734-8. [DOI] [PubMed] [Google Scholar]
  32. Moser P. C., Tricklebank M. D., Middlemiss D. N., Mir A. K., Hibert M. F., Fozard J. R. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Br J Pharmacol. 1990 Feb;99(2):343–349. doi: 10.1111/j.1476-5381.1990.tb14706.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Racké K., Schwörer H. Regulation of serotonin release from the intestinal mucosa. Pharmacol Res. 1991 Jan;23(1):13–25. doi: 10.1016/s1043-6618(05)80101-x. [DOI] [PubMed] [Google Scholar]
  34. Robinson D. S., Alms D. R., Shrotriya R. C., Messina M., Wickramaratne P. Serotonergic anxiolytics and treatment of depression. Psychopathology. 1989;22 (Suppl 1):27–36. doi: 10.1159/000284624. [DOI] [PubMed] [Google Scholar]
  35. Sanberg P. R., Russell K. H., Hagenmeyer-Houser S. H., Giordano M., Zubrycki E. M., Garver D. L. Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol. Psychopharmacology (Berl) 1989;99(1):60–63. doi: 10.1007/BF00634453. [DOI] [PubMed] [Google Scholar]
  36. Sharp T., McQuade R., Bramwell S., Hjorth S. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1993 Oct;348(4):339–346. doi: 10.1007/BF00171331. [DOI] [PubMed] [Google Scholar]
  37. Tricklebank M. D., Forler C., Fozard J. R. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol. 1984 Nov 13;106(2):271–282. doi: 10.1016/0014-2999(84)90714-3. [DOI] [PubMed] [Google Scholar]
  38. Weber L. J. p-Chlorophenylalanine depletion of gastrointestinal 5-hydroxytryptamine. Biochem Pharmacol. 1970 Jun;19(6):2169–2172. doi: 10.1016/0006-2952(70)90317-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES